Drug Pricing
California
Governor Newsom’s troubling first act on medications
In one of his first acts, Governor Newsom signed an executive order that will change how medicines are purchased in California. With visions of big-box store discounts dancing in his head, Governor Newsom has established a bulk program that will now purchase drugs for the state’s Medicaid program (Medi-Cal). The ...
Wayne Winegarden
January 17, 2019
Commentary
A Market-Based Solution to Rising Drug Prices: More Competition
By Henry I. Miller, M.S., M.D. and John J. Cohrssen President Trump and high-ranking officials in his administration, including Health and Human Services Secretary Alex Azar, Council of Economic Advisers Chairman Kevin Hassett and acting White House chief of staff Mick Mulvaney, are scheduled to meet tomorrow for a strategy ...
Pacific Research Institute
January 14, 2019
Commentary
New Study Championing Medicare for All Is Bogus
Sen. Bernie Sanders’ 2017 Medicare for All bill (S.1804) would guarantee exceptional care to all Americans while reducing health spending by $5.11 trillion. At least that’s what a new study from researchers at the University of Massachusetts-Amherst’s Political Economy Research Institute, which is co-directed by Professor Robert Pollin, claims. Sound too good ...
Sally C. Pipes
January 4, 2019
Business & Economics
Drug Prices That Matter
Too often, drug pricing analyses do not shed light on how much drug expenditures are actually increasing because these studies examine the wrong price. The latest iteration is an analysis by Rx Savings Solutions. According to the Wall Street Journal, Rx Savings Solutions documented that dozens of drug makers raised the ...
Wayne Winegarden
January 3, 2019
Commentary
Bernie Sanders’ drug price controls would stifle medical innovation
Sen. Bernie Sanders, I-Vt., and Rep. Ro Khanna, D-Calif., recently proposed bills that would impose price controls on prescription drugs. The legislation would require pharmaceutical companies to sell their medicines in the United States for no more than the median price charged in five countries – Canada, the United Kingdom, France, Germany, ...
Sally C. Pipes
December 11, 2018
Commentary
After Midterms, Democrats Inch Toward Government-Run Health Care
The midterm elections were good to Democrats. They took the majority in the U.S. House and captured several state legislatures. Public frustration with health care was a big reason why. Just before the election, seven in 10 voters said that the issue was “very important” when deciding whom to vote ...
Sally C. Pipes
December 10, 2018
Business & Economics
The Bizarre World of Drug Pricing
There is no shortage of bad ideas when it comes to the pharmaceutical market. One such proposal would allow drugs to be imported directly from other countries, such as Canada. Then there is the Trump Administration’s proposal that would effectively adopt foreign price controls on Medicare Part B drugs by ...
Wayne Winegarden
November 19, 2018
Drug Pricing
Sally Pipes Talks ‘Reinsurance’ Obamacare Fix in Washington Times
‘Reinsurance’ Obamacare fix wins bipartisan support in Senate By Tom Howell, Jr. Sen. Joe Manchin III, a West Virginia Democrat who just won re-election in one of the country’s reddest states, has an idea to fix Obamacare — call in President Trump. The West Virginian is among senators on both ...
Pacific Research Institute
November 14, 2018
Commentary
Putting Drug Prices on TV Will Cause Unnecessary Patient Panic
Last month, the Trump administration proposed several reforms to drive down prescription drug prices. One measure would force pharmaceutical companies to mention the sticker prices of their medicines in television advertisements. The new mandate covers all prescriptions drugs reimbursed by Medicare or Medicaid that cost more than $35 a month. The administration hopes this ...
Sally C. Pipes
November 9, 2018
Business & Economics
Wayne Winegarden Talks Drug Pricing Transparency on Lars Larson Show
Listen to PRI’s senior fellow in business and economics Dr. Wayne Winegarden discuss President Trump’s drug pricing transparency proposal on the nationally-syndicated “Lars Larson Show.” The interview begins at the 54:25 mark.
Pacific Research Institute
October 31, 2018
Governor Newsom’s troubling first act on medications
In one of his first acts, Governor Newsom signed an executive order that will change how medicines are purchased in California. With visions of big-box store discounts dancing in his head, Governor Newsom has established a bulk program that will now purchase drugs for the state’s Medicaid program (Medi-Cal). The ...
A Market-Based Solution to Rising Drug Prices: More Competition
By Henry I. Miller, M.S., M.D. and John J. Cohrssen President Trump and high-ranking officials in his administration, including Health and Human Services Secretary Alex Azar, Council of Economic Advisers Chairman Kevin Hassett and acting White House chief of staff Mick Mulvaney, are scheduled to meet tomorrow for a strategy ...
New Study Championing Medicare for All Is Bogus
Sen. Bernie Sanders’ 2017 Medicare for All bill (S.1804) would guarantee exceptional care to all Americans while reducing health spending by $5.11 trillion. At least that’s what a new study from researchers at the University of Massachusetts-Amherst’s Political Economy Research Institute, which is co-directed by Professor Robert Pollin, claims. Sound too good ...
Drug Prices That Matter
Too often, drug pricing analyses do not shed light on how much drug expenditures are actually increasing because these studies examine the wrong price. The latest iteration is an analysis by Rx Savings Solutions. According to the Wall Street Journal, Rx Savings Solutions documented that dozens of drug makers raised the ...
Bernie Sanders’ drug price controls would stifle medical innovation
Sen. Bernie Sanders, I-Vt., and Rep. Ro Khanna, D-Calif., recently proposed bills that would impose price controls on prescription drugs. The legislation would require pharmaceutical companies to sell their medicines in the United States for no more than the median price charged in five countries – Canada, the United Kingdom, France, Germany, ...
After Midterms, Democrats Inch Toward Government-Run Health Care
The midterm elections were good to Democrats. They took the majority in the U.S. House and captured several state legislatures. Public frustration with health care was a big reason why. Just before the election, seven in 10 voters said that the issue was “very important” when deciding whom to vote ...
The Bizarre World of Drug Pricing
There is no shortage of bad ideas when it comes to the pharmaceutical market. One such proposal would allow drugs to be imported directly from other countries, such as Canada. Then there is the Trump Administration’s proposal that would effectively adopt foreign price controls on Medicare Part B drugs by ...
Sally Pipes Talks ‘Reinsurance’ Obamacare Fix in Washington Times
‘Reinsurance’ Obamacare fix wins bipartisan support in Senate By Tom Howell, Jr. Sen. Joe Manchin III, a West Virginia Democrat who just won re-election in one of the country’s reddest states, has an idea to fix Obamacare — call in President Trump. The West Virginian is among senators on both ...
Putting Drug Prices on TV Will Cause Unnecessary Patient Panic
Last month, the Trump administration proposed several reforms to drive down prescription drug prices. One measure would force pharmaceutical companies to mention the sticker prices of their medicines in television advertisements. The new mandate covers all prescriptions drugs reimbursed by Medicare or Medicaid that cost more than $35 a month. The administration hopes this ...
Wayne Winegarden Talks Drug Pricing Transparency on Lars Larson Show
Listen to PRI’s senior fellow in business and economics Dr. Wayne Winegarden discuss President Trump’s drug pricing transparency proposal on the nationally-syndicated “Lars Larson Show.” The interview begins at the 54:25 mark.